Madrigal Pharmaceuticals (NASDAQ:MDGL) Downgraded by StockNews.com

StockNews.com downgraded shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Rating) from a hold rating to a sell rating in a research note released on Saturday morning. MDGL has been the topic of a number of other research reports. Oppenheimer upped their target price on shares of Madrigal Pharmaceuticals from $300.00 to $350.00 in a report […]

Related Keywords

China , ,Bradley Co ,Russell Investments Group Ltd ,Madrigal Pharmaceuticals Stock Performance ,China Universal Asset Management Co ,Madrigal Pharmaceuticals Inc ,Hedge Funds Weigh In On Madrigal Pharmaceuticals ,News Ratings For Madrigal Pharmaceuticals Daily ,Wealth Management ,Analyst Recommendations For Madrigal Pharmaceuticals ,Nisa Investment Advisors ,Canaccord Genuity Group ,Madrigal Pharmaceuticals ,Get Rating ,Genuity Group ,Moderate Buy ,Private Wealth Management ,Capital Partners ,Investments Group ,Investment Advisors ,China Universal Asset Management ,Universal Asset Management ,Madrigal Pharmaceuticals Daily ,Nasdaq Mdgl ,Mdgl ,Medical ,87162t20 ,Downgrade ,Stocknews Com ,